Zengtong Zhou

2.3k total citations
65 papers, 1.6k citations indexed

About

Zengtong Zhou is a scholar working on Periodontics, Oral Surgery and Molecular Biology. According to data from OpenAlex, Zengtong Zhou has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Periodontics, 17 papers in Oral Surgery and 16 papers in Molecular Biology. Recurrent topics in Zengtong Zhou's work include Oral Health Pathology and Treatment (45 papers), Oral and Maxillofacial Pathology (17 papers) and Head and Neck Cancer Studies (15 papers). Zengtong Zhou is often cited by papers focused on Oral Health Pathology and Treatment (45 papers), Oral and Maxillofacial Pathology (17 papers) and Head and Neck Cancer Studies (15 papers). Zengtong Zhou collaborates with scholars based in China, United States and Thailand. Zengtong Zhou's co-authors include Wei Liu, Linjun Shi, Xuemin Shen, Jinqiu Feng, Shi Peng, Wei‐Wen Jiang, Lan Wu, Guoyao Tang, Zhengyu Shen and Jie Wei and has published in prestigious journals such as PLoS ONE, Cancer and International Journal of Cancer.

In The Last Decade

Zengtong Zhou

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zengtong Zhou China 22 836 579 366 364 290 65 1.6k
S. Kannan India 18 190 0.2× 571 1.0× 93 0.3× 232 0.6× 251 0.9× 63 1.1k
Kuo‐Wei Tai Taiwan 16 402 0.5× 209 0.4× 185 0.5× 88 0.2× 116 0.4× 19 752
H Tanzawa Japan 22 157 0.2× 891 1.5× 55 0.2× 152 0.4× 367 1.3× 40 1.5k
Lucyana Conceição Farias Brazil 17 65 0.1× 347 0.6× 83 0.2× 90 0.2× 191 0.7× 60 766
Carlos Alberto de Carvalho Fraga Brazil 18 69 0.1× 323 0.6× 60 0.2× 104 0.3× 209 0.7× 58 796
Gregor Heiduschka Austria 18 35 0.0× 390 0.7× 45 0.1× 230 0.6× 148 0.5× 95 1.1k
Ying Gu United States 17 297 0.4× 265 0.5× 49 0.1× 20 0.1× 96 0.3× 28 879
Tetsuya Tamatani Japan 21 35 0.0× 521 0.9× 117 0.3× 54 0.1× 297 1.0× 52 1.1k
Xiaoshan Feng China 22 141 0.2× 777 1.3× 34 0.1× 31 0.1× 455 1.6× 62 1.4k
Charles A. Lesch United States 17 85 0.1× 307 0.5× 32 0.1× 20 0.1× 250 0.9× 24 1.1k

Countries citing papers authored by Zengtong Zhou

Since Specialization
Citations

This map shows the geographic impact of Zengtong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengtong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengtong Zhou more than expected).

Fields of papers citing papers by Zengtong Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengtong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengtong Zhou. The network helps show where Zengtong Zhou may publish in the future.

Co-authorship network of co-authors of Zengtong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zengtong Zhou. A scholar is included among the top collaborators of Zengtong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zengtong Zhou. Zengtong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Yongmei, et al.. (2023). Salvianolic acid B as a potent nano‐agent for enhanced ALA‐PDT of oral cancer and leukoplakia cells. Oral Diseases. 30(3). 1091–1099. 2 indexed citations
3.
Liu, Wei, Meng Li, Xinzhong Zhang, et al.. (2022). Association of polymorphisms in Th1/Th2-related cytokines (IFN-γ, TGFβ1, IL-1β, IL-2, IL-4, IL-18) with oral lichen planus: A pooled analysis of case–control studies. Journal of Dental Sciences. 18(2). 560–566. 13 indexed citations
6.
Wu, Wenyan, et al.. (2019). Risk Factors Associated With Malignant Transformation in Patients With Oral Leukoplakia in a Chinese Population: A Retrospective Study. Journal of Oral and Maxillofacial Surgery. 77(12). 2483–2493. 14 indexed citations
7.
Li, Hongquan, Linjun Shi, Jie Wei, et al.. (2016). Cellular uptake and anticancer activity of salvianolic acid B phospholipid complex loaded nanoparticles in head and neck cancer and precancer cells. Colloids and Surfaces B Biointerfaces. 147. 65–72. 41 indexed citations
8.
Shen, Zhengyu, Chenping Zhang, Zengtong Zhou, et al.. (2016). Altered expression of interleukin-17A and its targeting microRNAs in oral lichen planus: a pilot study. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 122(5). 619–624.e1. 9 indexed citations
9.
Shen, Zhengyu, et al.. (2013). Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus. Annals of Diagnostic Pathology. 17(5). 408–411. 8 indexed citations
10.
Wang, Hao, et al.. (2013). Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma. Annals of Diagnostic Pathology. 17(4). 327–330. 19 indexed citations
11.
Liu, Wei, Lan Wu, Xuemin Shen, et al.. (2012). Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia. International Journal of Cancer. 132(4). 868–874. 69 indexed citations
12.
Ma, Liwei, et al.. (2012). Phosphorylated p120-catenin expression has predictive value for oral cancer progression. Journal of Clinical Pathology. 65(4). 315–319. 22 indexed citations
13.
Wu, Lan, Jinqiu Feng, Linjun Shi, et al.. (2012). Candidal infection in oral leukoplakia: a clinicopathologic study of 396 patients from eastern China. Annals of Diagnostic Pathology. 17(1). 37–40. 26 indexed citations
14.
Liu, Wei, et al.. (2011). Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases. Journal of Oral Pathology and Medicine. 40(4). 312–316. 20 indexed citations
15.
Wang, Yufeng, et al.. (2011). [A retrospective analysis on the malignant transformation rate, time and risk factors of oral leukoplakia].. PubMed. 20(1). 55–61. 2 indexed citations
16.
Shen, Zhengyu, et al.. (2011). Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation?. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 112(5). 592–596. 22 indexed citations
17.
Wei, Jie, Guoxiang Xie, Yunping Qiu, et al.. (2011). Metabolic Transformation of DMBA-Induced Carcinogenesis and Inhibitory Effect of Salvianolic Acid B and Breviscapine Treatment. Journal of Proteome Research. 11(2). 1302–1316. 37 indexed citations
18.
Zhang, Jinhe & Zengtong Zhou. (2007). [Oral lichen planus: a retrospective study of 724 Chinese patients].. PubMed. 42(11). 669–71. 10 indexed citations
19.
Yan, Shikai, et al.. (2007). A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncology. 44(5). 477–483. 76 indexed citations
20.
Zhou, Zengtong, et al.. (2005). The preventive effect of salvianolic acid B on malignant transformation of DMBA-induced oral premalignant lesion in hamsters. Carcinogenesis. 27(4). 826–832. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026